Development and Function of B Cell Subsets

Molecular Biology of B Cells: Second Edition

Volumn , Issue , 2015, Pages 99-119

  Vale, Andre M ^a   Kearney, John F ^b   Nobrega, Alberto ^a   Schroeder, Harry W ^b,c,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

B 1 B cells; B cell development; B cell subsets; Follicular B cells; Marginal zone B cells

Indexed keywords

EID: 84942109052     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397933-9.00007-2     Document Type: Chapter

References (224)

1. Hardy R.R., Hayakawa K. B cell development pathways. Annu Rev Immunol 2001, 19:595-621.
2. Hardy R.R., William Chapter 7: B lymphocyte development and biology. Fundamental immunology (book) 2008, 237-269. Lippincott Williams & Wilkins, Philadelphia. 6th ed. P. William (Ed.).
3. Rolink A.G., Andersson J., Melchers F. Molecular mechanisms guiding late stages of B-cell development. Immunol Rev 2004, 197:41-50.
4. Nemazee D., Weigert M. Revising B cell receptors. J Exp Med 2000, 191:1813-1817.
5. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006, 6:728-740.
6. Goodnow C.C. Balancing immunity, autoimmunity, and self-tolerance. Ann NY Acad Sci 1997, 815:55-66.
7. Rolink A., Melchers F. B-cell development in the mouse. Immunol Lett 1996, 54:157-161.
8. Osmond D.G., Rolink A.G., Melchers F. Murine B lymphopoiesis: towards a unified model. Immunol Today 1998, 19:65-68.
9. Kantor A.B., Stall A.M., Adams S., Herzenberg L.A., Herzenberg L.A. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci USA 1992, 89:3320-3324.
10. Stall A.M., Adams S., Herzenberg L.A., Kantor A.B. Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann NY Acad Sci 1992, 651:33-43.
11. Dorshkind K., Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol 2007, 7:213-219.
12. Pillai S., Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009, 9:767-777.
13. Schroeder H.W. Similarity and divergence in the development and expression of the mouse and human antibody repertoires. Dev Comp Immunol 2005, 30:119-135.
14. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991, 12:154-159.
15. Hooijkaas H., Benner R., Pleasants J.R., Wostmann B.S. Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered "antigen-free" diet. Eur J Immunol 1984, 14:1127-1130.
16. Haury M., Sundblad A., Grandien A., Barreau C., Coutinho A., Nobrega A. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 1997, 27:1557-1563.
17. Bos N.A., Kimura H., Meeuwsen C.G., De V.H., Hazenberg M.P., Wostmann B.S., et al. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol 1989, 19:2335-2339.
18. Briles D.E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J Exp Med 1981, 153:694-705.
19. Benedict C.L., Kearney J.F. Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity 1999, 10:607-617.
20. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999, 286:2156-2159.
21. Kaveri S.V., Silverman G.J., Bayry J. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol 2012, 188:939-945.
22. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 2011, 11:34-46.
23. Baumgarth N. Innate-like B cells and their rules of engagement. Adv Exp Med Biol 2013, 785:57-66.
24. Hu L., Rezanka L.J., Mi Q.S., Lustig A., Taub D.D., Longo D.L., et al. T15-idiotype-negative B cells dominate the phosphocholine binding cells in the preimmune repertoire of T15i knockin mice. J Immunol 2002, 168:1273-1280.
25. Stall A.M., Wells S.M., Lam K.P. B-1 cells: unique origins and functions. Semin Immunol 1996, 8:45-59.
26. Bendelac A., Bonneville M., Kearney J.F. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 2001, 1:177-186.
27. Montecino-Rodriguez E., Dorshkind K. B-1 B cell development in the fetus and adult. Immunity 2012, 36:13-21.
28. + CD70. J Exp Med 2011, 208:67-80.
29. + human B1 cell subpopulation stimulates T cells and is expanded in lupus. J Exp Med 2011, 208(13):2591-2598.
30. Martin F., Kearney J.F. Marginal-zone B cells. Nat Rev Immunol 2002, 2:323-335.
31. Pillai S., Cariappa A., Moran S.T. Marginal zone B cells. Annu Rev Immunol 2005, 23:161-196.
32. Weill J.C., Weller S., Reynaud C.A. Human marginal zone B cells. Annu Rev Immunol 2009, 27:267-285.
33. - B lymphocyte subsets. Eur J Immunol 1982, 12:564-569.
34. Oliver A.M., Martin F., Gartland G.L., Carter R.H., Kearney J.F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997, 27:2366-2374.
35. Song J., Lokmic Z., Lammermann T., Rolf J., Wu C., Zhang X., et al. Extracellular matrix of secondary lymphoid organs impacts on B-cell fate and survival. Proc Natl Acad Sci USA 2013, 110:E2915-E2924.
36. Kumararatne D.S., Bazin H., MacLennan I.C. Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol 1981, 11:858-864.
37. Attanavanich K., Kearney J.F. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol 2004, 172:803-811.
38. Balazs M., Martin F., Zhou T., Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002, 17:341-352. [see comment].
39. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
40. Cinamon G., Zachariah M.A., Lam O.M., Foss F.W., Cyster J.G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 2008, 9:54-62.
41. Timens W. The human spleen and the immune system: not just another lymphoid organ. Res Immunol 1991, 142:316-320.
42. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003, 197:939-945.
43. Weller S., Braun M.C., Tan B.K., Rosenwald A., Cordier C., Conley M.E., et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004, 104:3647-3654.
44. Zandvoort A., Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 2002, 130:4-11.
45. Forster I., Rajewsky K. The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow. Proc Natl Acad Sci USA 1990, 87:4781-4784.
46. Victora G.D., Nussenzweig M.C. Germinal centers. Annu Rev Immunol 2012, 30:429-457.
47. Okamoto M., Murakami M., Shimizu A., Ozaki S., Tsubata T., Kumagai S., et al. A transgenic model of autoimmune hemolytic anemia. J Exp Med 1992, 175:71-79.
48. Cariappa A., Pillai S. Antigen-dependent B-cell development. Curr Opin Immunol 2002, 14:241-249.
49. Amano H., Amano E., Moll T., Marinkovic D., Ibnou-Zekri N., Martinez-Soria E., et al. The Yaa mutation promoting murine lupus causes defective development of marginal zone B cells. J Immunol 2003, 170:2293-2301.
50. Ippolito G.C., Schelonka R.L., Zemlin M., Ivanov I.I., Kobayashi R., Zemlin C., et al. Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. J Exp Med 2006, 203:1567-1578.
51. Schelonka R.L., Zemlin M., Kobayashi R., Szalai A., Ippolito G.C., Zhuang Y., et al. Preferential use of D H reading frame 2 alters B cell development and antigen-specific antibody production. J Immunol 2008, 181:8409-8415.
52. Berland R., Wortis H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002, 20:253-300.
53. Vale A.M., Schroeder H.W. Clinical consequences of defects in B-cell development. J Allergy Clin Immunol 2010, 125:778-787.
54. Ivanov I.I., Schelonka R.L., Zhuang Y., Gartland G.L., Zemlin M., Schroeder H.W. Development of the expressed immunoglobulin CDR-H3 repertoire is marked by focusing of constraints in length, amino acid utilization, and charge that are first established in early B cell progenitors. J Immunol 2005, 174:7773-7780.
55. Hardy R.R., Carmack C.E., Shinton S.A., Kemp J.D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 1991, 173:1213-1225.
56. Montecino-Rodriguez E., Leathers H., Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol 2006, 7:293-301.
57. Herzenberg L.A., Tung J.W. B cell lineages: documented at last!. Nat Immunol 2006, 7:225-226.
58. Hayakawa K., Hardy R.R., Herzenberg L.A. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med 1985, 161:1554-1568.
59. Haas K.M., Poe J.C., Steeber D.A., Tedder T.F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005, 23:7-18.
60. Tung J.W., Herzenberg L.A. Unraveling B-1 progenitors. Curr Opin Immunol 2007, 19:150-155.
61. Lalor P.A., Stall A.M., Adams S., Herzenberg L.A. Permanent alteration of the murine LY-1 B repertoire due to selective depletion of LY-1 B cells in neonatal animals. Eur J Immunol 1989, 19:501-506.
62. Herzenberg L.A. B-1 cells: the lineage question revisited. Immunol Rev 2000, 175:9-22.
63. Schroeder H.W., Hillson J.L., Perlmutter R.M. Early restriction of the human antibody repertoire. Science 1987, 238:791-793.
64. Schroeder H.W., Mortari F., Shiokawa S., Kirkham P.M., Elgavish R.A., Bertrand F.E. Developmental regulation of the human antibody repertoire. Ann NY Acad Sci 1995, 764:242-260.
65. Bertrand F.E., Billips L.G., Schroeder H.W. Analysis of DHQ52 gene segment transcription and rearrangement during B-cell development in human fetal bone marrow. Ann NY Acad Sci 1995, 764:228-230.
66. Yancopoulos G.D., Alt F.W. Regulation of the assembly and expression of variable region genes. Annu Rev Immunol 1986, 4:339-368.
67. Schelonka R.L., Szymanska E., Vale A.M., Zhuang Y., Gartland G.L., Schroeder H.W. DH and JH usage in murine fetal liver mirrors that of human fetal liver. Immunogenetics 2010, 62:653-666.
68. Desiderio S.V., Yancopoulos G.D., Paskind M., Thomas E., Boss M.A., Landau N.R., et al. Insertion of N regions into heavy-chain gene is correlated with expression of terminal deoxytransferase in B cells. Nature 1984, 311:752-755.
69. Feeney A.J. Lack of N regions in fetal and neonatal mouse immunoglobulin V-D-J junctional sequences. J Exp Med 1990, 172:1377-1390.
70. Feeney A.J. Predominance of VH-D-JH junctions occurring at sites of short sequence homology results in limited junctional diversity in neonatal antibodies. J Immunol 1992, 149:222-229.
71. Gu H., Forster I., Rajewsky K. Sequence homologies, N sequence insertion and JH gene utilization in VH-D-JH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation. EMBO J 1990, 9:2133-2140.
72. Tornberg U.C., Holmberg D. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures. EMBO J 1995, 14:1680-1689.
73. Kantor A.B., Merrill C.E., Herzenberg L.A., Hillson J.L. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 1997, 158:1175-1186.
74. Vale A.M., Tanner J.M., Schelonka R.L., Zhuang Y., Zemlin M., Gartland G.L., et al. The peritoneal cavity B-2 antibody repertoire appears to reflect many of the same selective pressures that shape the B-1a and B-1b repertoires. J Immunol 2010, 185:6085-6095.
75. Lam K.P., Rajewsky K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med 1999, 190:471-477.
76. Binder C.J., Horkko S., Dewan A., Chang M.K., Kieu E.P., Goodyear C.S., et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003, 9:736-743.
77. Chou M.Y., Fogelstrand L., Hartvigsen K., Hansen L.F., Woelkers D., Shaw P.X., et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 2009, 119:1335-1349.
78. Vale A.M., Kapoor P., Skibinski G.A., Elgavish A., Mahmoud T.I., Zemlin C., et al. The link between antibodies to OxLDL and natural protection against pneumococci depends on DH gene conservation. J Exp Med 2013, 210:875-890.
79. Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytol 1992, 132:31-74.
80. Koike R., Nishimura T., Yasumizu R., Tanaka H., Hataba Y., Hataba Y., et al. The splenic marginal zone is absent in alymphoplastic aly mutant mice. Eur J Immunol 1996, 26:669-675.
81. Cyster J.G. B cell follicles and antigen encounters of the third kind. Nat Immunol 2010, 11:989-996.
82. Carsetti R., Kohler G., Lamers M.C. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995, 181:2129-2140.
83. Allman D.M., Ferguson S.E., Lentz V.M., Cancro M.P. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J Immunol 1993, 151:4431-4444.
84. Loder F., Mutschler B., Ray R.J., Paige C.J., Sideras P., Torres R., et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999, 190:75-89.
85. Allman D., Lindsley R.C., DeMuth W., Rudd K., Shinton S.A., Hardy R.R. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001, 167:6834-6840.
86. Pillai S., Cariappa A., Moran S.T. Positive selection and lineage commitment during peripheral B-lymphocyte development. Immunol Rev 2004, 197:206-218.
87. Meyer-Bahlburg A., Andrews S.F., Yu K.O., Porcelli S.A., Rawlings D.J. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med 2008, 205:155-168.
88. Osmond D.G. The turnover of B-cell populations. Immunol Today 1993, 14:34-37.
89. Allman D., Pillai S. Peripheral B cell subsets. Curr Opin Immunol 2008, 20:149-157.
90. Cancro M.P., Kearney J.F. B cell positive selection: road map to the primary repertoire?. J Immunol 2004, 173:15-19.
91. Wen L., Brill-Dashoff J., Shinton S.A., Asano M., Hardy R.R., Hayakawa K. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 2005, 23:297-308.
92. Norvell A., Mandik L., Monroe J.G. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J Immunol 1995, 154:4404-4413.
93. Su T.T., Rawlings D.J. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol 2002, 168:2101-2110.
94. Gaudin E., Rosado M., Agenes F., McLean A., Freitas A.A. B-cell homeostasis, competition, resources, and positive selection by self-antigens. Immunol Rev 2004, 197:102-115.
95. Hardy R.R., Hayakawa K. Positive and negative selection of natural autoreactive B cells. Adv Exp Med Biol 2012, 750:227-238.
96. Cambier J.C., Gauld S.B., Merrell K.T., Vilen B.J. B-cell anergy: from transgenic models to naturally occurring anergic B cells?. Nat Rev Immunol 2007, 7:633-643.
97. Shlomchik M.J., Weisel F. Germinal center selection and the development of memory B and plasma cells. Immunol Rev 2012, 247:52-63.
98. Shapiro-Shelef M., Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005, 230-242.
99. King C. New insights into the differentiation and function of T follicular helper cells. Nat Rev Immunol 2009, 9:757-766.
100. Ma C.S., Deenick E.K., Batten M., Tangye S.G. The origins, function, and regulation of T follicular helper cells. J Exp Med 2012, 209:1241-1253.
101. McHeyzer-Williams M., Okitsu S., Wang N., McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol 2012, 12:24-34.
102. Bortnick A., Chernova I., Quinn W.J., Mugnier M., Cancro M.P., Allman D. Long-lived bone marrow plasma cells are induced early in response to T cell-independent or T cell-dependent antigens. J Immunol 2012, 188:5389-5396.
103. Foote J.B., Mahmoud T.I., Vale A.M., Kearney J.F. Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells. J Immunol 2012, 188:57-67.
104. Tarlinton D., Good-Jacobson K. Diversity among memory B cells: origin, consequences, and utility. Science 2013, 341:1205-1211.
105. Lopes-Carvalho T., Kearney J.F. Development and selection of marginal zone B cells. Immunol Rev 2004, 197:192-205.
106. Cariappa A., Tang M., Parng C., Nebelitskiy E., Carroll M., Georgopoulos K., et al. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001, 14:603-615.
107. Srivastava B., Quinn W.J., Hazard K., Erikson J., Allman D. Characterization of marginal zone B cell precursors. J Exp Med 2005, 202:1225-1234.
108. Cariappa A., Boboila C., Moran S.T., Liu H., Shi H.N., Pillai S. The recirculating B cell pool contains two functionally distinct, long-lived, posttransitional, follicular B cell populations. J Immunol 2007, 179:2270-2281.
109. Lopes-Carvalho T., Foote J., Kearney J.F. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 2005, 17:244-250.
110. Schelonka R.L., Tanner J., Zhuang Y., Gartland G.L., Zemlin M., Schroeder H.W. Categorical selection of the antibody repertoire in splenic B cells. Eur J Immunol 2007, 37:1010-1021.
111. Nolte M.A., Arens R., Kraus M., van Oers M.H., Kraal G., van Lier R.A., et al. B cells are crucial for both development and maintenance of the splenic marginal zone. J Immunol 2004, 172:3620-3627.
112. + dendritic cells in the generation of cytotoxic T cells. Proc Natl Acad Sci USA 2010, 107:216-221.
113. Aichele P., Zinke J., Grode L., Schwendener R.A., Kaufmann S.H., Seiler P. Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J Immunol 2003, 171:1148-1155.
114. Odermatt B., Eppler M., Leist T.P., Hengartner H., Zinkernagel R.M. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci USA 1991, 88:8252-8256.
115. Chen Y., Pikkarainen T., Elomaa O., Soininen R., Kodama T., Kraal G., et al. Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J Immunol 2005, 175:8173-8180.
116. Yokota T., Ehlin-Henriksson B., Hansson G.K. Scavenger receptors mediate adhesion of activated B lymphocytes. Exp Cell Res 1998, 239:16-22.
117. You Y., Myers R.C., Freeberg L., Foote J., Kearney J.F., Justement L.B., et al. Marginal zone B cells regulate antigen capture by marginal zone macrophages. J Immunol 2011, 186:2172-2181.
118. Koppel E.A., Litjens M., van den Berg V.C., van Kooyk Y., Geijtenbeek T.B. Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae. Mol Immunol 2008, 45:2881-2887.
119. You Y., Zhao H., Wang Y., Carter R.H. Cutting edge: primary and secondary effects of CD19 deficiency on cells of the marginal zone. J Immunol 2009, 182:7343-7347.
120. Steiniger B., Timphus E.M., Barth P.J. The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants. Histochem Cell Biol 2006, 126:641-648.
121. Steiniger B., Timphus E.M., Jacob R., Barth P.J. CD27+ B cells in human lymphatic organs: re-evaluating the splenic marginal zone. Immunology 2005, 116:429-442.
122. Nascimbeni M., Perie L., Chorro L., Diocou S., Kreitmann L., Louis S., et al. Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression. Blood 2009, 113:6112-6119.
123. + dendritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp. Immunology 2008, 123:438-446.
124. Steiniger B., Stachniss V., Schwarzbach H., Barth P.J. Phenotypic differences between red pulp capillary and sinusoidal endothelia help localizing the open splenic circulation in humans. Histochem Cell Biol 2007, 128:391-398.
125. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998, 391:799-803.
126. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 1999, 286:2098-2102.
127. Guinamard R., Okigaki M., Schlessinger J., Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 2000, 1:31-36.
128. Fukui Y., Hashimoto O., Sanui T., Oono T., Koga H., Abe M., et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature 2001, 412:826-831.
129. Girkontaite I., Missy K., Sakk V., Harenberg A., Tedford K., Potzel T., et al. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat Immunol 2001, 2:855-862.
130. Ansel K.M., Harris R.B., Cyster J.G. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002, 16:67-76.
131. Ha S.A., Tsuji M., Suzuki K., Meek B., Yasuda N., Kaisho T., et al. Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 2006, 203:2541-2550.
132. Lo C.G., Lu T.T., Cyster J.G. Integrin-dependence of lymphocyte entry into the splenic white pulp. J Exp Med 2003, 197:353-361.
133. Lu T.T., Cyster J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002, 297:409-412.
134. Mackay F., Schneider P. Cracking the BAFF code. Nat Rev Immunol 2009, 9:491-502.
135. Mackay F., Browning J.L. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002, 2:465-475.
136. Rolink A.G., Tschopp J., Schneider P., Melchers F. BAFF is a survival and maturation factor for mouse B cells. Eur J Immunol 2002, 32:2004-2010.
137. Schneider P., Takatsuka H., Wilson A., Mackay F., Tardivel A., Lens S., et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med 2001, 194:1691-1697.
138. Rauch M., Tussiwand R., Bosco N., Rolink A.G. Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells. PloS One 2009, 4:e5456.
139. Lindsley R.C., Thomas M., Srivastava B., Allman D. Generation of peripheral B cells occurs via two spatially and temporally distinct pathways. Blood 2007, 109:2521-2528.
140. Kreuzaler M., Rauch M., Salzer U., Birmelin J., Rizzi M., Grimbacher B., et al. Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. J Immunol 2012, 188:497-503.
141. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710.
142. Thien M., Phan T.G., Gardam S., Amesbury M., Basten A., Mackay F., et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004, 20:785-798.
143. Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000, 288:2222-2226.
144. Zeng D., Lee M.K., Tung J., Brendolan A., Strober S. Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J Immunol 2000, 164:5000-5004.
145. Ochsenbein A.F., Zinkernagel R.M. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000, 21:624-630.
146. Sindhava V.J., Scholz J.L., Cancro M.P. Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells. Front Immunol 2013, 4:37.
147. Bossen C., Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 2006, 18:263-275.
148. Casola S. Control of peripheral B-cell development. Curr Opin Immunol 2007, 19:143-149.
149. Gerondakis S., Siebenlist U. Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol 2010, 2:a000182.
150. -/- mice. J Exp Med 2001, 194:1141-1150.
151. Vosshenrich C.A., Cumano A., Muller W., Di Santo J.P., Vieira P. Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development. Nat Immunol 2003, 4:773-779.
152. Jensen C.T., Kharazi S., Boiers C., Liuba K., Jacobsen S.E. TSLP-mediated fetal B lymphopoiesis?. Nat Immunol 2007, 8:897. author reply 898.
153. Herzenberg L.A. Toward a layered immune system. Cell 1989, 59:953-954.
154. Lam K.P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997, 90:1073-1083.
155. Kraus M., Alimzhanov M.B., Rajewsky N., Rajewsky K. Survival of resting mature B lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer. Cell 2004, 117:787-800.
156. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991, 350:423-426.
157. Monroe J.G. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol 2006, 6:283-294.
158. Schweighoffer E., Vanes L., Nys J., Cantrell D., McCleary S., Smithers N., et al. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. Immunity 2013, 38:475-488.
159. Stadanlick J.E., Kaileh M., Karnell F.G., Scholz J.L., Miller J.P., Quinn W.J., et al. Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling. Nat Immunol 2008, 9:1379-1387.
160. Martin F., Kearney J.F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000, 12:39-49.
161. Li Y., Li H., Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med 2002, 195:181-188.
162. Watanabe N., Ikuta K., Fagarasan S., Yazumi S., Chiba T., Honjo T. Migration and differentiation of autoreactive B-1 cells induced by activated gamma/delta T cells in antierythrocyte immunoglobulin transgenic mice. J Exp Med 2000, 192:1577-1586.
163. Ohdan H., Swenson K.G., Kruger Gray H.S., Yang Y.G., Xu Y., Thall A.D., et al. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice. J Immunol 2000, 165:5518-5529.
164. Boes M., Prodeus A.P., Schmidt T., Carroll M.C., Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998, 188:2381-2386.
165. Su I., Tarakhovsky A. B-1 cells: orthodox or conformist?. Curr Opin Immunol 2000, 12:191-194.
166. Casola S., Otipoby K.L., Alimzhanov M., Humme S., Uyttersprot N., Kutok J.L., et al. B cell receptor signal strength determines B cell fate. Nat immunol 2004, 5:317-327.
167. Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol 2004, 4:348-359.
168. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
169. Kabat E.A., Wu T.T., Perry H.M., Gottesman K.S., Foeller C. Sequences of proteins of immunological interest 1991, U.S.Department of Health and Human Services, Bethesda, Maryland. 5th ed.
170. Padlan E.A. Anatomy of the antibody molecule. Mol Immunol 1994, 31:169-217.
171. Xu J.L., Davis M.M. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 2000, 13:37-45.
172. Schroeder H.W., Zemlin M., Khass M., Nguyen H.H., Schelonka R.L. Genetic control of DH reading frame and its effect on B-cell development and antigen-specifc antibody production. Crit Rev Immunol 2010, 30:327-344.
173. Kearney J.F. Innate-like B cells. Springer Semin Immunopathol 2005, 26:377-383.
174. Baumgarth N., Herman O.C., Jager G.C., Brown L.E., Herzenberg L.A., Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000, 192:271-280.
175. Baumgarth N., Herman O.C., Jager G.C., Brown L., Herzenberg L.A. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 1999, 96:2250-2255.
176. Aprahamian T., Rifkin I., Bonegio R., Hugel B., Freyssinet J.M., Sato K., et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 2004, 199:1121-1131.
177. Binder C.J., Silverman G.J. Natural antibodies and the autoimmunity of atherosclerosis. Springer Semin Immunopathol 2005, 26:385-404.
178. Shaw P.X., Horkko S., Chang M.K., Curtiss L.K., Palinski W., Silverman G.J., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000, 105:1731-1740.
179. Chen Y., Park Y.B., Patel E., Silverman G.J. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol 2009, 182:6031-6043.
180. Kearney J.F. Innate-like B cells. Springer Semin Immunopathol 2005, 26:377-383.
181. Potter M., Leon M.A. Three IgA myeloma immunoglobulins from the BALB/mouse: precipitation with pneumococcal C polysaccharide. Science 1968, 162:369-371.
182. Gearhart P.J., Sigal N.H., Klinman N.R. Heterogeneity of the BALB/c antiphosphorylcholine antibody response at the precursor cell level. J Exp Med 1975, 141:56-71.
183. Sigal N.H., Gearhart P.J., Klinman N.R. The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB/C mice. J Immunol 1975, 114:1354-1358.
184. Levy M. Frequencies of phosphorylcholine-specific and T15-associated 10/13 idiotope-positive B cells within lipopolysaccharide-reactive B cells of adult BALB/c mice. Eur J Immunol 1984, 14:864-868.
185. Feeney A.J., Clarke S.H., Mosier D.E. Specific H chain junctional diversity may be required for non-T15 antibodies to bind phosphorylcholine. J Immunol 1988, 141:1267-1272.
186. Crews S., Griffin J., Huang H., Calame K., Hood L. A single VH gene segment encodes the immune response to phosphorylcholine: somatic mutation is correlated with the class of the antibody. Cell 1981, 25:59-66.
187. Briles D.E., Forman C., Hudak S., Claflin J.L. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J Exp Med 1982, 156:1177-1185.
188. Maynard C.L., Elson C.O., Hatton R.D., Weaver C.T. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012, 489:231-241.
189. + T cells shape the abundance of marginal zone B cells. Eur J Immunol 2008, 38:3411-3425.
190. Murakami M., Nakajima K., Yamazaki K., Muraguchi T., Serikawa T., Honjo T. Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell autoantibody transgenic mice. J Exp Med 1997, 185:791-794.
191. Genestier L., Taillardet M., Mondiere P., Gheit H., Bella C., Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol 2007, 178:7779-7786.
192. Rawlings D.J., Schwartz M.A., Jackson S.W., Meyer-Bahlburg A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat Rev Immunol 2012, 12:282-294.
193. Oliver A.M.1, Martin F., Kearney J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol Jun 15, 1999, 162(12):7198-7207.
194. Kirkland D., Benson A., Mirpuri J., Pifer R., Hou B., DeFranco A.L., et al. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 2012, 36:228-238.
195. Wang J., Taniuchi I., Maekawa Y., Howard M., Cooper M.D., Watanabe T. Expression and function of Fas antigen on activated murine B cells. Eur J Immunol 1996, 26:92-96.
196. Fredrickson T.N., Lennert K., Chattopadhyay S.K., Morse H.C., Hartley J.W. Splenic marginal zone lymphomas of mice. Am J Pathol 1999, 154:805-812.
197. Rothstein T.L., Wang J.K., Panka D.J., Foote L.C., Wang Z., Stanger B., et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995, 374:163-165.
198. Lagresle C., Mondiere P., Bella C., Krammer P.H., Defrance T. Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis. J Exp Med 1996, 183:1377-1388.
199. Hirose S., Yan K., Abe M., Jiang Y., Hamano Y., Tsurui H., et al. Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination. Proc Natl Acad Sci USA 1997, 94:9291-9295.
200. + B cells predominate in peripheral tissues of rabbit. J Immunol 1992, 149:3858-3864.
201. Knabel M., Cihak J., Losch U. Characterization of new monoclonal antibodies identifying avian T lymphocyte antigens. Immunobiology 1993, 188:415-429.
202. Jurgens J.B., Gartland L.A., Du Pasquier L., Horton J.D., Gobel T.W., Cooper M.D. Identification of a candidate CD5 homologue in the amphibian Xenopus laevis. J Immunol 1995, 155:4218-4223.
203. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000, 404:995-999.
204. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000, 192:1453-1466.
205. Tachibana I., Hemler M.E. Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol 1999, 146:893-904.
206. Cook G.A., Wilkinson D.A., Crossno J.T., Raghow R., Jennings L.K. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin. Exp Cell Res 1999, 251:356-371.
207. Rathmell J.C., Townsend S.E., Xu J.C., Flavell R.A., Goodnow C.C. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 1996, 87:319-329.
208. Fagarasan S., Honjo T. T-Independent immune response: new aspects of B cell biology. Science 2000, 290:89-92.
209. Dighiero G., Borche L. Evidence that the B lymphocyte proliferating in B-CLL and in other B-cell malignancies is frequently committed to production of natural autoantibodies. Nouv Rev Fr Hematol 1990, 32:323-326.
210. Smith K.G., Nossal G.J., Tarlinton D.M. FAS is highly expressed in the germinal center but is not required for regulation of the B-cell response to antigen. Proc Natl Acad Sci USA 1995, 92:11628-11632.
211. Le Naour F., Rubinstein E., Jasmin C., Prenant M., Boucheix C. Severely reduced female fertility in CD9-deficient mice. Science 2000, 287:319-321.
212. Coutinho A.A. Beyond clonal selection and network. Immunol Rev 1989, 110:63-87.
213. Coutinho A., Forni L., Holmberg D., Ivars F., Vaz N. From an antigen-centered, clonal perspective of immune responses to an organism-centered, network perspective of autonomous activity in a self-referential immune system. Immunol Rev 1984, 79:151-168.
214. Grandien A., Fucs R., Nobrega A., Andersson J., Coutinho A. Negative selection of multireactive B cell clones in normal adult mice. Eur J Immunol 1994, 24:1345-1352.
215. Crowley J.E., Treml L.S., Stadanlick J.E., Carpenter E., Cancro M.P. Homeostatic niche specification among naive and activated B cells: a growing role for the BLyS family of receptors and ligands. Semin Immunol 2005, 17:193-199.
216. Chu V.T., Berek C. The establishment of the plasma cell survival niche in the bone marrow. Immunol Rev 2013, 251:177-188.
217. Manz R.A., Hauser A.E., Hiepe F., Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005, 23:367-386.
218. Mauri C., Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012, 30:221-241.
219. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008, 224:201-214.
220. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol 2010, 10:236-247.
221. Cerutti A., Cols M., Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 2013, 13:118-132.
222. Garraud O., Borhis G., Badr G., Degrelle S., Pozzetto B., Cognasse F., et al. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol 2012, 13:63.
223. Swanson C.L., Pelanda R., Torres R.M. Division of labor during primary humoral immunity. Immunol Res 2013, 55:277-286.
224. Vinuesa C.G., Chang P.P. Innate B cell helpers reveal novel types of antibody responses. Nat Immunol 2013, 14:119-126.